Brian Caveney is Chief Medical and Scientific Officer, Head of Enterprise Strategy and President, Early Development Research Laboratories at Labcorp. In his current role, Brian leads all medical and scientific affairs, enterprise strategy, oncology, cell and gene therapy, global early development research laboratories and quality compliance for Labcorp. He previously served as President of Diagnostics.
Brian has been instrumental in accelerating growth in the company’s diagnostics business and advancing its medical and scientific strategy. Under his leadership, the company has advanced diagnostic testing services, introduced over 1,000 new assays across key therapeutic areas, and expanded its hospital strategy. During the COVID-19 pandemic, Brian led efforts to expand the accessibility of PCR testing, used his expertise to help bring understanding about testing and treatment options to the public, and drove advancements to the way the company works with the broader healthcare industry.
Before joining Labcorp in 2017, Brian was the Chief Medical Officer at Blue Cross and Blue Shield of North Carolina. In addition to various roles in the healthcare division of the core health plan, Brian also served as Chief Clinical Officer of Mosaic Health Solutions, a wholly-owned subsidiary of Blue Cross NC, for strategic investments in diversified health solutions businesses. Previously, he was a practicing physician and assistant professor at Duke University Medical Center.
Brian serves on the Board of Directors of the Personalized Medicine Coalition, the Healthcare Leadership Council, and North Carolina Healthcare Quality Alliance. He is a Board Observer for CND Life Sciences, Inc. He obtained both medical and law degrees from West Virginia University, and a Master of Public Health from the University of North Carolina at Chapel Hill. He completed his residency at Duke University Medical Center and is board certified in preventive medicine, with a specialty in occupational and environmental medicine.
